Monoclonal Antibodies for Pre- and Postexposure Prophylaxis of COVID-19: Review of the Literature
Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful microorganisms, including viruses such as Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-CoV-2). The US Food and Drug Administration (FDA) and the European Medical Agency (EMA) have...
| Päätekijät: | , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
MDPI AG
2022-08-01
|
| Sarja: | Pathogens |
| Aiheet: | |
| Linkit: | https://www.mdpi.com/2076-0817/11/8/882 |